Phase II Clinical Development of New Drugs
HC runder Rücken kaschiert
Print on Demand | Lieferzeit: Print on Demand - Lieferbar innerhalb von 3-5 Werktagen I
136,80 €*
Alle Preise inkl. MwSt.|Versandkostenfrei
ISBN-13:
9789811041921
Veröffentl:
2017
Einband:
HC runder Rücken kaschiert
Erscheinungsdatum:
24.04.2017
Seiten:
260
Autor:
Naitee Ting
Gewicht:
559 g
Format:
241x160x20 mm
Serie:
ICSA Book Series in Statistics
Sprache:
Englisch
Beschreibung:
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
First comprehensive book on the design and analysis of Phase II clinical trials
Chapter 1 Introduction.- Chapter 2 Concept of Alpha.- Chapter 3 Confirmation and Exploration.- Chapter 4 Design a Proof of Concept (PoC) Trial.- Chapter 5 Design of Dose-Ranging Trials.- Chapter 6 Combining PoC and Dose Ranging Trials.- Chapter 7 Risks of Inconclusiveness.- Chapter 8 Analysis of a PoC Study.- Chapter 9 Data Analysis for Dose-Ranging Trials with Continuous Outcome.- Chapter 10 Data Analysis of Dose-Ranging Trials for Binary Outcomes.- Chapter 11 Bayesian Methods.- Chapter 12 Overview of Phase III Clinical Trials.
Kunden Rezensionen
Mehr zum Thema
Folgen Sie uns auf:
